Back to Journals » ClinicoEconomics and Outcomes Research » Volume 13

Results of a Time and Motion Survey Regarding Subcutaneous versus Intravenous Administration of Daratumumab in Patients with Relapsed or Refractory Multiple Myeloma

Total article views   HTML views PDF downloads Totals
7,607 Dovepress* 6,718+ 838 7,556
PubMed Central* 889 353 1,242
Totals 7,607 1,191 8,798
*Since 8 June 2021
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 1 5

View citations on PubMed Central and Google Scholar